Mrs Dominique Costagliola, PhD - INSERM and Sorbonne Universités, UPMC Univ Paris 06 - Senior Researcher

Mrs Dominique Costagliola

PhD

INSERM and Sorbonne Universités, UPMC Univ Paris 06

Senior Researcher

Paris | France

Main Specialties: Biology

Additional Specialties: Epidemiology, Biostatistics, HIV infection

Mrs Dominique Costagliola, PhD - INSERM and Sorbonne Universités, UPMC Univ Paris 06 - Senior Researcher

Mrs Dominique Costagliola

PhD

Introduction

Primary Affiliation: INSERM and Sorbonne Universités, UPMC Univ Paris 06 - Paris , France

Specialties:

Additional Specialties:

Publications

100Publications

2708Reads

-Profile Views

2282PubMed Central Citations

[Not Available].

Therapie 2012 Jul-Aug;67(4):375-80. Epub 2012 Nov 1.

Université Pierre et Marie Curie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2515/therapie/2012049DOI Listing
April 2016
10 Reads
0.400 Impact Factor

Characteristics of B-cell lymphomas in HIV/HCV-coinfected patients.

J Acquir Immune Defic Syndr 2014 Oct;67(2):e86-7

*Department of Internal Medicine, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Université Paris 5 Descartes, Paris, France †Department of Internal Medicine, Hôpital Pitié-Salpétrière ‡INSERM U943 §Université Paris 6 Pierre et Marie Curie UMR S 943, Paris, France ‖Université Paris-Sud, UFR Médecine, Paris, France ¶Hematology and Immunology Department #Inserm U-1012, Hôpital Bicêtre Le Kremlin Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000272DOI Listing
October 2014
9 Reads
1 Citation
4.560 Impact Factor

Heterosexual risk of HIV transmission per sexual act under combined antiretroviral therapy: systematic review and bayesian modeling.

Clin Infect Dis 2014 Jul 9;59(1):115-22. Epub 2014 Apr 9.

Unité d'Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciu223DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305135PMC
July 2014
19 Reads
8 Citations
8.890 Impact Factor

The undiagnosed HIV epidemic in France and its implications for HIV screening strategies.

AIDS 2014 Jul;28(12):1797-804

aSorbonne Universités, UPMC Univ Paris 06 bINSERM, UMR_S 1136 Pierre Louis Institute of Epidemiology and Public Health, Paris, France cInstituto de Salud Carlos III, Madrid, Spain dHarvard School of Public Health, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000270DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262966PMC
July 2014
4 Reads
21 Citations
5.554 Impact Factor

T-cell activation positively correlates with cell-associated HIV-DNA level in viremic patients with primary or chronic HIV-1 infection.

AIDS 2014 Jul;28(11):1683-7

aUniversité Paris Descartes, Sorbonne Paris Cité bInstitut Pasteur, Régulation des infections rétrovirales cAP-HP Hôpital Européen Georges Pompidou dUniversité Paris Diderot, Sorbonne Paris Cité eINSERM U943 fUniversité Pierre et Marie Curie gAP-HP Hôpital Saint-Antoine hUniversité Paris Descartes, EA 3620, Paris, France. *Present address: Urology Research Unit, Lausanne University Hospital, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000319DOI Listing
July 2014
12 Reads
6 Citations
5.554 Impact Factor

Demographics of HIV and aging.

Curr Opin HIV AIDS 2014 Jul;9(4):294-301

aSorbonne Universités, UPMC Univ Paris 06 bINSERM, UMRS 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COH.0000000000000076DOI Listing
July 2014
38 Reads
14 Citations
4.680 Impact Factor

HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens.

Clin Infect Dis 2014 Jun 18;58(12):1763-70. Epub 2014 Mar 18.

INSERM, UMR912 (SESSTIM) Aix Marseille Université, UMR_S912, IRD ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciu187DOI Listing
June 2014
34 Reads
18 Citations
8.890 Impact Factor

Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study.

J Antimicrob Chemother 2014 Jun 16;69(6):1648-52. Epub 2014 Feb 16.

INSERM, UMRS 943, Paris F-75013, France UPMC Univ Paris 06, UMRS 943, Paris F-75013, France Department of Virology, AP-HP, Pitié-Salpêtrière Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkt536DOI Listing
June 2014
7 Reads
8 Citations
5.313 Impact Factor

Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC).

Int J Epidemiol 2014 Jun 18;43(3):691-702. Epub 2013 Apr 18.

School of Social and Community Medicine, University of Bristol, Bristol, UK, UPMC Univ Paris 06, UMR_S 943, F-75013, Paris, France; INSERM, UMR_S 943, F-75013, Paris, France; AP-HP, Hôpital Pitié-Salpétrière, Service des maladies infectieuses et tropicales, F-75013, Paris, France, Yale University School of Medicine, New Haven, CT, USA, VA Connecticut Healthcare System, West Haven, CT, USA, Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, University Hospital Lausanne, Lausanne, Switzerland, Clinic of Infectious Diseases & Tropical Medicine, San Paolo Hospital, University of Milan, Italy, Centre d'Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya, Badalona, Spain, Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada, Research Department of Infection and Population Health, UCL Medical School, London, UK, INSERM U.897, ISPED, Université Bordeaux, Bordeaux, France, Department of Internal Medicine University of Cologne, DE, Vanderbilt University School of Medicine, Nashville, TN, USA, National Epidemiology Center. Carlos III Health Institute, Madrid, Spain, Division of Infectious Diseases, University of Calgary, Calgary, Canada, University of Washington School of Medicine, Seattle, WA, USA, Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham, USA, HIV Atlanta VA Cohort Study (HAVACS), Atlanta Veterans Affairs Medical Center, Decatur, GA, USA and Johann Wolfgang Goethe-Universität, HIVCENTER, Frankfurt, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ije/dyt010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052127PMC
June 2014
84 Reads
26 Citations
9.180 Impact Factor

Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000.

AIDS 2014 May;28(8):1181-91

aINSERM, ISPED, Centre INSERM U897-Epidémiologie-Biostatistiques bService de Médecine Interne et Maladies Infectieuses, Hôpital Saint-André, CHU de Bordeaux cUniversity Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistiques, Bordeaux dService de Maladies Infectieuses, Hôpital Brabois, Vandoeuvre-Les-Nancy eUnité de Pathologie Infectieuse, Pôle Médecine, Hôpital Cochin, AP-HP fUniversité Paris Descartes gDepartment of Internal Medicine and Immunology, AP-HP Hôpital La Pitié-Salpêtrière hDépartement Hospitalo-universitaire I2B, UPMC Univ Paris 06, UMR 7211, Paris iINSERM-CépiDC, Le Kremlin-Bicêtre jService de Médecine Interne, Hôpital de l'Archet kUniversité de Nice-Sophia Antipolis, Nice lService des Maladies Infectieuses et Tropicales, Hôpital Purpan, Toulouse mService des Maladies Infectieuses et Tropicales, Hôpitaux Universitaires Paris Nord Val de Seine nUniversité Paris 7 oINSERM, UMR-S 1136 pSorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Paris qCHU de Bordeaux, Pole de Santé Publique, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000222DOI Listing
May 2014
70 Reads
38 Citations
5.554 Impact Factor

Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.

J Acquir Immune Defic Syndr 2014 Jan;65(1):e8-16

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e3182a39979DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894575PMC
January 2014
108 Reads
58 Citations
4.560 Impact Factor

Impact of late presentation on the risk of death among HIV-infected people in France (2003-2009).

J Acquir Immune Defic Syndr 2013 Oct;64(2):197-203

*INSERM U943, Paris, France; †UPMC Paris Univ 06 UMR S 943, Paris, France; ‡Assistance Publique Hôpitaux de Paris (AP-HP), Hôpital Avicenne, Service de maladies infectieuses et tropicales, Bobigny, France; §Centre Hospitalier de Nanterre, Service de médecine interne, maladies infectieuses et rhumatologie, Nanterre, France; ‖Centre Hospitalo-Universitaire de Nice, Hôpital de l'Archet, Service des Maladies Infectieuses et Tropicales, Nice, France; ¶Université Paris Descartes, Paris, France; #Assistance Publique Hôpitaux de Paris (AP-HP), Hôpital Cochin, Pôle de Médecine, Paris, France; **Assistance Publique-Hôpitaux de Paris, Hôpital Antoine Béclère, Service de Médecine Interne et Immunologie Clinique, Clamart, France; ††INSERM, UMR_S 996, Clamart, France; ‡‡Université Paris Sud, UMR_S 996, Clamart, France; §§Hôpitaux Universitaires de Strasbourg, Le trait d'Union, Strasbourg, France; ‖‖Centre Hospitalo-Universitaire de Nice, Hôpital de l'Archet, Département de santé publique, Nice, France; ¶¶Assistance Publique Hôpitaux de Paris (AP-HP), Hôpital Ambroise-Paré, Service de médecine, Boulogne, France; ##Assistance Publique Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Service de maladies infectieuses et tropicales, Paris, France; and ***Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Cochin Broca Hôtel-Dieu, Unité de Biostatistique et Epidémiologie, Paris, F-75004 France (C. Montlahuc is now with the Observatoire régional de Santé d'Ile de France, Paris, France).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e31829cfbfaDOI Listing
October 2013
49 Reads
21 Citations
4.560 Impact Factor

Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia.

AIDS 2013 Sep;27(15):2425-30

aINSERM bUPMC Univ Paris 06, UMRS 943 cAP-HP, Hôpital Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales dAP-HP, Centre de Diagnostic et de Thérapeutique, Hôtel-Dieu, Paris eAP-HP, Hôpital Avicenne, Service de maladies infectieuses, Bobigny fAP-HP, Hôpital Pitié-Salpêtrière, Service de médecines internes gRheumatology Department, Cochin Hospital, Paris-Descartes University hAP-HP, Hôpital Pitié-Salpêtrière, Service de Rhumatologie and UPMC Univ Paris 06, Paris, France.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/aidsonline/2013/09240/Changes_i
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/QAD.0b013e32836378c3DOI Listing
September 2013
28 Reads
7 Citations
5.554 Impact Factor

MHC-driven HIV-1 control on the long run is not systematically determined at early times post-HIV-1 infection.

AIDS 2013 Jul;27(11):1707-16

Epidemiology and Public Health Service, APHP, Hôpital du Kremlin Bicêtre, Université Paris-Sud, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e328360a4bdDOI Listing
July 2013
9 Reads
5 Citations
5.554 Impact Factor

Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.

J Antimicrob Chemother 2013 Jun 7;68(6):1388-99. Epub 2013 Feb 7.

UPMC University Paris 06, UMR_S 943, INSERM, F-75005, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkt011DOI Listing
June 2013
13 Reads
9 Citations
5.313 Impact Factor

Risk of cancers in HIV infection.

Enferm Infecc Microbiol Clin 2013 May 25;31(5):275-6. Epub 2013 Apr 25.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eimc.2013.04.001DOI Listing
May 2013
1.881 Impact Factor

β-Blocker use for patients with or at risk for coronary artery disease.

JAMA 2013 Feb;309(5):439

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2012.128862DOI Listing
February 2013
4 Reads
1 Citation
35.290 Impact Factor

HIV and coronary heart disease: time for a better understanding.

J Am Coll Cardiol 2013 Feb;61(5):511-23

Department of Cardiology, Saint Antoine Hospital, University of Paris, Paris, France.

View Article

Download full-text PDF

Source
http://content.onlinejacc.org/data/Journals/JAC/926287/06063
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S073510971204775
Publisher Site
http://dx.doi.org/10.1016/j.jacc.2012.06.063DOI Listing
February 2013
45 Reads
51 Citations
16.503 Impact Factor

Determinants of low-density lipoprotein particle diameter during antiretroviral therapy including protease inhibitors in HIV-1-infected patients.

Antivir Ther 2012 9;17(5):855-60. Epub 2012 Feb 9.

Unité Fonctionnelle de Biochimie des Maladies Métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP2065DOI Listing
January 2013
22 Reads
1 Citation
3.020 Impact Factor

Prevalence of low bone mineral density in men and women infected with human immunodeficiency virus 1 and a proposal for screening strategy.

J Clin Densitom 2012 Oct-Dec;15(4):422-433. Epub 2012 Jul 21.

Service de Rhumatologie, APHP, Hôpital Pitié-Salpêtrière, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocd.2012.04.001DOI Listing
January 2013
11 Reads
7 Citations
1.603 Impact Factor

Lack of regression of anal squamous intraepithelial lesions despite immune restoration under cART.

AIDS 2013 Jan;27(3):401-6

AP-HP-Service d'Immunologie Clinique, Hôpital Européen Georges Pompidou, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e32835ad2cbDOI Listing
January 2013
15 Reads
3 Citations
5.554 Impact Factor

Breast cancer among HIV infected individuals from the ONCOVIH study, in France: therapeutic implications.

Eur J Cancer 2012 Dec 3;48(18):3335-41. Epub 2012 Jul 3.

AP-HP, Groupe Hospitalier Pitié-Salpétrière, Département d'Oncologie Médicale du Prof. David Khayat, 47 Boulevard de l'Hôpital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2012.05.019DOI Listing
December 2012
5 Reads
4 Citations
5.420 Impact Factor

Undiagnosed HIV prevalence in France: no evidence against universal HIV screening.

AIDS 2012 Nov;26(18):2419; author reply 2419-21

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e32835a5bb4DOI Listing
November 2012
2 Reads
5.554 Impact Factor

[Impact of new antiretroviral therapy in HIV infected patients with virologic failure].

Med Sci (Paris) 2012 Aug-Sep;28(8-9):706-7. Epub 2012 Aug 22.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/2012288011DOI Listing
October 2012
5 Reads
0.520 Impact Factor

Effects of rosuvastatin versus pravastatin on low-density lipoprotein diameter in HIV-1-infected patients receiving ritonavir-boosted protease inhibitor.

AIDS 2012 Sep;26(14):1801-5

Unité Fonctionnelle de Biochimie des Maladies Métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Assistance Publique-Hôpitaux de Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e328357063cDOI Listing
September 2012
17 Reads
2 Citations
5.554 Impact Factor

Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).

AIDS Res Hum Retroviruses 2012 Sep 23;28(9):972-80. Epub 2012 Mar 23.

AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Rhumatologie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/AID.2011.0224DOI Listing
September 2012
34 Reads
10 Citations
2.330 Impact Factor

Bleeding complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction in a radial center.

Catheter Cardiovasc Interv 2012 Jan 8;79(1):104-12. Epub 2011 Dec 8.

Institut de Cardiologie (APHP), INSERM U937 and Univ Paris 6, Pitié-Salpêtrière Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.23164DOI Listing
January 2012
33 Reads
4 Citations
2.110 Impact Factor

Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients.

AIDS 2011 Sep;25(15):1813-22

INSERM UMR S, Infections and Immunity, Avenir Group, Université Pierre et Marie Curie-Paris, Hôpital Pitié-Salpêtrière, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e32834640e6DOI Listing
September 2011
78 Reads
47 Citations
5.554 Impact Factor

New method for estimating HIV incidence and time from infection to diagnosis using HIV surveillance data: results for France.

AIDS 2011 Sep;25(15):1905-13

INSERM U, Hôpital Pitié Salpêtrière, Service des Maladies Infectieuses et Tropicales, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e32834af619DOI Listing
September 2011
3 Reads
11 Citations
5.554 Impact Factor

Modelling the budget impact of darunavir in the treatment of highly treatment-experienced, HIV-infected adults in France.

Pharmacoeconomics 2010 ;28 Suppl 1:183-97

INSERM, Unité Mixte de Recherche (UMR) S 720, and Université Pierre et Marie Curie-Paris 6, UMR S 720, Paris, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.2165/11587520-000000000-00000
Publisher Site
http://dx.doi.org/10.2165/11587520-000000000-00000DOI Listing
April 2011
13 Reads
2.450 Impact Factor

The cost of managing HIV infection in highly treatment-experienced, HIV-infected adults in France.

Pharmacoeconomics 2010 ;28 Suppl 1:59-68

INSERM, Mixed Research Unit (UMR) S 720, and Université Pierre et Marie Curie-Paris 6, UMR S 720, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/11587450-000000000-00000DOI Listing
April 2011
3 Reads
2.450 Impact Factor

A therapeutic dendritic cell-based vaccine for HIV-1 infection.

J Infect Dis 2011 Feb 13;203(4):473-8. Epub 2011 Jan 13.

Infectious Diseases Department, Hospital Clinic - HIV Development Program in Catalonia, Institut d'Investigacions Biomédiques August Pi I Sunyer, University of Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiq077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071229PMC
February 2011
14 Reads
34 Citations
6.000 Impact Factor

Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention.

Catheter Cardiovasc Interv 2011 Feb;77(2):182-90

Department of Cardiology, Concord Hospital, University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ccd.22674
Publisher Site
http://dx.doi.org/10.1002/ccd.22674DOI Listing
February 2011
18 Reads
3 Citations
2.110 Impact Factor

Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis.

Eur Heart J 2011 Jan 21;32(1):41-50. Epub 2010 Oct 21.

Department of Cardiology, Saint Antoine Hospital, 184 rue du faubourg St-Antoine, Univ-Paris 6, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehq372DOI Listing
January 2011
25 Reads
14 Citations
15.203 Impact Factor

IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy--results from the ANRS CO4 cohort.

J Antimicrob Chemother 2010 Oct 11;65(10):2215-23. Epub 2010 Aug 11.

Département de santé publique, Centre Hospitalier Universitaire de Nice, Nice F-06003, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkq296DOI Listing
October 2010
20 Reads
3 Citations
5.313 Impact Factor

Distinct differentiation profiles of HIV-Gag and Nef-specific central memory CD8+ T cells associated with HLA-B57/5801 and virus control.

AIDS 2010 Sep;24(15):2323-9

Laboratoire d'Immunité et Infections, INSERM, UMR-S 945, Hôpital Pitié-Salpêtrière, UPMC Univ Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e32833e5009DOI Listing
September 2010
14 Reads
8 Citations
5.554 Impact Factor

Abacavir and cardiovascular risk: reviewing the evidence.

Curr HIV/AIDS Rep 2010 Aug;7(3):127-33

UMR S 943, UPMC Univ-Paris 6, Paris, F75013, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11904-010-0047-3DOI Listing
August 2010
17 Reads
11 Citations

Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion.

J Natl Cancer Inst 2010 Jun 4;102(11):784-92. Epub 2010 May 4.

Medical Research Council, Clinical Trials Unit, 222 Euston Rd, London NW1 2DA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djq134DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879418PMC
June 2010
17 Reads
29 Citations
12.583 Impact Factor

Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults.

Int J Cancer 2010 Apr;126(7):1724-31

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.24931DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818159PMC
April 2010
7 Reads
18 Citations
5.085 Impact Factor

Relative contributions of baseline patient characteristics and the choice of statistical methods to the variability of genotypic resistance scores: the example of didanosine.

J Antimicrob Chemother 2010 Apr 17;65(4):752-60. Epub 2010 Feb 17.

INSERM, U943, Paris, F-75013 France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkq034DOI Listing
April 2010
4 Reads
3 Citations
5.313 Impact Factor

HIV-associated tuberculosis and immigration in a high-income country: incidence trends and risk factors in recent years.

AIDS 2010 Mar;24(5):763-71

INSERM U 943, Hopital Avicenne, Service de maladies infectieuses ettropicales, Bobigny, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e3283366747DOI Listing
March 2010
15 Reads
13 Citations
5.554 Impact Factor

Early initiation of treatment for HIV infection.

Lancet 2010 Feb;375(9715):639

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(10)60269-3DOI Listing
February 2010
2 Reads
1 Citation
45.220 Impact Factor

Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy.

AIDS 2010 Feb;24(4):614-7

UPMC Univ Paris 06, INSERM, UMR945, AP-HP, Laboratoire d'Immunologie Cellulaire et Tissulaire, Hôpital Pitié-Salpêtrière, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e32833556f3DOI Listing
February 2010
18 Reads
18 Citations
5.554 Impact Factor

Enoxaparin anticoagulation monitoring in the catheterization laboratory using a new bedside test.

J Am Coll Cardiol 2010 Feb;55(7):617-25

Institut de Cardiologie, Institut National de la Santé et de la Recherche Médicale (INSERM) CMR937, Pitié-Salpêtrière Hospital (AP-HP), Université Paris 6, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2009.08.077DOI Listing
February 2010
5 Reads
4 Citations
16.503 Impact Factor

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.

Lancet Oncol 2009 Dec 7;10(12):1152-9. Epub 2009 Oct 7.

INSERM U943 and UPMC UMR-S-943, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(09)70282-7DOI Listing
December 2009
18 Reads
157 Citations
24.690 Impact Factor

[Towards a vaccine for HIV infection: role of the gp41 envelope protein].

Bull Acad Natl Med 2009 Jan;193(1):127-36; discussion 137-8

Laboratoire Immunité et Infection, Inserm UMR 945, Hôpital Pitié Salpêtrière, Université Pierre et Marie Curie, 83 Bld de l'Hôpital, 75013 Paris.

View Article

Download full-text PDF

Source
January 2009
13 Reads
0.220 Impact Factor

Top co-authors

Lambert Assoumou
Lambert Assoumou

Université Paris Descartes

15
Christine Katlama
Christine Katlama

Pitié-Salpêtrière Hospital

12
Brigitte Autran
Brigitte Autran

Université Pierre et Marie Curie

11
Emilie Lanoy
Emilie Lanoy

Harvard School of Public Health

10
Laurence Meyer
Laurence Meyer

Université Paris Sud

10
Anne Simon
Anne Simon

College Park

9
Christine Rouzioux
Christine Rouzioux

Université Paris Descartes

9
Amanda Mocroft
Amanda Mocroft

Royal Free and University College Medical School

9
Marguerite Guiguet
Marguerite Guiguet

Université Pierre et Marie Curie

8
Bernard Masquelier
Bernard Masquelier

Laboratoire de Virologie

8